| 标题 |
专利、报告等 Efficacy and safety of furmonertinib plus anlotinib as first-line treatment for locally advanced or metastatic NSCLC patients: a single-arm, phase I/II trial |
| 网址 | |
| DOI |
10.2139/ssrn.5420401
doi
|
| 其它 |
期刊: 作者:Huiyang Shi; Haohua Zhu; Le Tang; Jingyu Lu; Kai Zhu; et al 出版日期:2025-09-09 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)